Abstract

BackgroundDetermination of the relaxation time constants T1 and T2 with quantitative magnetic resonance imaging is increasingly used for both research and clinical practice. Recently, groups have been formed within the Society of Cardiovascular Magnetic Resonance to address issues with relaxometry. However, so far they have avoided specific recommendations on methodology due to lack of consensus and current evolving research. Standardised widely available software may simplify this process.The purpose of the current study was to develop and validate vendor-independent T1 and T2 mapping modules and implement those in the versatile and widespread software Segment, freely available for research and FDA approved for clinical applications.ResultsThe T1 and T2 mapping modules were developed and validated in phantoms at 1.5 T and 3 T with reference standard values calculated from reference pulse sequences using the Nelder-Mead Simplex optimisation method. The proposed modules support current commonly available MRI pulse sequences and both 2- and 3-parameter curve fitting. Images acquired in patients using three major vendors showed vendor-independence. Bias and variability showed high agreement with T1 and T2 reference standards for T1 (range 214–1752 ms) and T2 (range 45–338 ms), respectively.ConclusionsThe developed and validated T1 and T2 mapping and quantification modules generated relaxation maps from current commonly used MRI sequences and multiple signal models. Patient applications showed usability for three major vendors.

Highlights

  • Determination of the relaxation time constants T1 and T2 with quantitative magnetic resonance imaging is increasingly used for both research and clinical practice

  • Phantom validation results are shown for 1.5 T and 3 T (Fig. 2) and corresponding curve fit examples at 1.5 T (Fig. 3)

  • The higher variability for modified Look-Locker inversion recovery (MOLLI) was related to low T2, with errors above 5 % originating from phantoms with reference T2 values < 60 ms

Read more

Summary

Introduction

Determination of the relaxation time constants T1 and T2 with quantitative magnetic resonance imaging is increasingly used for both research and clinical practice. Groups have been formed within the Society of Cardiovascular Magnetic Resonance to address issues with relaxometry. They have avoided specific recommendations on methodology due to lack of consensus and current evolving research. Quantitative magnetic resonance imaging (MRI) is increasingly used for several different applications in both research and clinical practice. The Society of Cardiovascular Magnetic Resonance (SCMR) has recently formed groups and provides general recommendations on use of mapping. Oxygen saturation in blood has been accurately measured noninvasively by T2 mapping in children with complex congenital heart disease, yielding an opportunity

Objectives
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.